CHRNB2 p.Tyr221=
c.663C>T · rs765825095 · VCV2746867
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -4.5 | GERP -2.6 |
| Overall | ||
| CADD | 6.476 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00167% | 60,030 |
| African / African-American | 0.00133% | 75,022 |
| European (non-Finnish) | 8.47e-05% | 1,180,040 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHRNB2
- Protein
- p.Tyr221=
- Coding
- c.663C>T
- MANE Select
- NM_000748
- dbSNP
- rs765825095
- Type
- single nucleotide variant
- Location
- chr1:154571486 (GRCh38)
- Gene constraint
- LOEUF 1.116 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.16 · 15 PDB
Disease context
familial sleep-related hypermotor epilepsy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Sleep-related hypermotor epilepsy (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult, Childhood
Similar variants
- CHRNB2 p.Val287Leu Pathogenic/Likely pathogenic ★★ same condition
- CHRNB2 p.Val287Met Pathogenic ★★ same condition
- CHRNB2 p.Val308Ala Pathogenic/Likely pathogenic ★★ same condition
- CHRNB2 c.1338+3G>T Uncertain significance ★★ same condition
- CHRNB2 c.366-3C>T Uncertain significance ★★ same condition
- CHRNB2 p.Ala135Val Uncertain significance ★★ ⚠ same condition
- CHRNB2 p.Ala154Thr Uncertain significance ★★ ⚠ same condition
- CHRNB2 p.Ala207Gly Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chrnb2-p-tyr221 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown